BMC Musculoskeletal Disorders Volume 8
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Study protocolEffects of laterally wedged insoles on symptoms and disease progression in medial knee osteoarthritis: a protocol for a randomised, double-blind, placebo controlled trialKim Bennell1 , Kelly-Ann Bowles1 , Craig Payne2 , Flavia Cicuttini3 , Richard Osborne4 , Anthony Harris5 and Rana Hinman1  1Centre for Health, Exercise & Sports Medicine, School of Physiotherapy, University of Melbourne, Australia 2Department of Podiatry, School of Human Biosciences, LaTrobe University, Melbourne, Australia 3Department of Epidemiology and Preventive Medicine, Alfred Hospital, Monash University, Melbourne, Australia 4AFV Centre for Rheumatic Diseases, Department of Medicine (RMH/WH), University of Melbourne, Australia 5Health Economics Unit, Monash University, Melbourne, Australia author email corresponding author email
BMC Musculoskeletal Disorders 2007,
8:96doi:10.1186/1471-2474-8-96
|
|
| Published: |
24 September 2007 |
Abstract
Background
Whilst laterally wedged insoles, worn inside the shoes, are advocated as a simple, inexpensive, non-toxic self-administered intervention for knee osteoarthritis (OA), there is currently limited evidence to support their use. The aim of this randomised, double-blind controlled trial is to determine whether laterally wedges insoles lead to greater improvements in knee pain, physical function and health-related quality of life, and slower structural disease progression as well as being more cost-effective, than control flat insoles in people with medial knee OA.
Methods/Design
Two hundred participants with painful radiographic medial knee OA and varus malalignment will be recruited from the community and randomly allocated to lateral wedge or control insole groups using concealed allocation. Participants will be blinded as to which insole is considered therapeutic. Blinded follow up assessment will be conducted at 12 months after randomisation. The outcome measures are valid and reliable measures recommended for OA clinical trials. Questionnaires will assess changes in pain, physical function and health-related quality-of-life. Magnetic resonance imaging will measure changes in tibial cartilage volume. To evaluate cost-effectiveness, participants will record the use of all health-related treatments in a log-book returned to the assessor on a monthly basis. To test the effect of the intervention using an intention-to-treat analysis, linear regression modelling will be applied adjusting for baseline outcome values and other demographic characteristics.
Discussion
Results from this trial will contribute to the evidence regarding the effectiveness of laterally wedged insoles for the management of medial knee OA.
Trial registration
ACTR12605000503628; NCT00415259. |